InsiderClue
← All stocks

Viridian Therapeutics, Inc.\DE

VRDN Net buying
CIK 0001590750 #1814 in the set updated 17 Sep 2026
Bought (12 mo)
$30.00M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$418.99K
$0.00 on a plan · $348.19K straight out of an exercise
Sold at will
$70.80K
1 of 3 sales
Net
+$29.58M
+$29.93M against sales at will

By person

6 insiders · 6 transactions
1.1×

Stephen Mahoney holds only 1.1 times base salary in stock. $811.69K of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Stephen Mahoney last reported holding, valued at $24.50, the price Common Stock was last bought or sold at on the open market here, on 19 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Fairmount Funds Management LLC entity
Director
$30.00M (2)
—
+$30.00M
5,090,928
4.49%
$124.73M
+47.7%
Tousignant Jennifer
Chief Legal Officer
—
$418.99K (3) scheduled
−$418.99K
0
0.0000%
$0.00
−100.0%
Tripuraneni Radhika
Chief Medical Officer
—
—
—
40,000
0.0353%
$980.00K
—
Mahoney Stephen F.
President and CEO
—
—
—
33,130
0.0292%
$811.69K
+3,213%
Beetham Thomas W.
Chief Operating Officer
—
—
—
13,271
0.0117%
$325.14K
+563.6%
Harmon Seth
Chief Financial Officer
—
—
—
7,790
0.0069%
$190.86K
+115.6%

Individual transactions

2
Insider
Date
Role
Action
Shares
Price
Amount
Tousignant Jennifer
19 Aug 2026
Chief Legal Officer
Sold after exercise
10,000
$24.50
$245.00K
Tousignant Jennifer
19 Aug 2026
Chief Legal Officer
Sold after exercise
4,212
$24.50
$103.19K
Show all 6 transactions →

What was left out

Form 4 filings counted 16
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 103,782
History held since 2 Nov 2016